(Q57904490)

English

Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer

No description defined

Statements

Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
Nicoletta Colombo
0 references
Elzbieta Kutarska
0 references
Duk-Soo Bae
0 references
Dirk Weber
0 references
Mona El-Hashimy
0 references
Jingjin Li
0 references
Farida Souami
0 references
Patricia Wing
0 references
Silke Engelholm
0 references
Aristotelis Bamias
0 references
Peter Schwartz
0 references
November 2012
0 references
30
0 references
31
0 references
3841-3847
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit